Articles, Videos and Items of General Interest
Corona virus (COVID-19)
Data, Resources and Updates Link HERE
State Health Departments Link
Army, Navy and Air Force medical personnel care for Soldiers, Sailors, Airmen, Marines, Coast Guardsmen and all who come in harm's way -- on and off the battlefield.
Featured Item of Interest
The Largest burn pit in Iraq was located at Balad Air Base. On average, 147 tons of refuse was burned a day. The toxic fumes were breathed in by the 25,000 American Soldiers stationed there.
Ruling on Burn Pit Link to Cancers and a Rare Lung Disease Coming from VA Next Year
The Department of Veterans Affairs plans to announce in 2022 whether some forms of cancer and a rare lung disorder seen in patients exposed to burn pits and other forms of pollution should entitle veterans to expedited benefits and disability compensation.
VA Secretary Denis McDonough said Thursday that the VA will announce "early next year" whether some cancers will be deemed as connected to military service, and for constrictive bronchiolitis -- a rare disease that affects the lungs' smallest passageways -- by summer 2022. Read more on this ruling HERE
Young and Dying: Veterans Are Getting Brain Cancer and Struggling to Get Benefits
"We're all assuming it's the burn pits," said Noah Feehan, who deployed to both Iraq and Afghanistan. "It was disgusting what they threw in there. Tires, jet fuel, body parts, plastics."
While traumatic brain injuries and post-traumatic stress disorder have been called the "signature wounds" of the Iraq and Afghanistan wars, affecting nearly half a million troops, thousands of veterans also have been diagnosed with diseases possibly connected to environmental hazards and toxic waste.
Hundreds, like Feehan, are fighting or have succumbed to glioblastoma, the most common form of brain cancer, striking roughly 12,000 Americans each year. Read further on this horrific story HERE
Are Burn Pits the new Agent Orange of this generation?
Featured Item of Interest
Is the United States Dependent on China for Pharmaceuticals?
Since the COVID-19 pandemic revealed weak links in global supply chains, US policymakers have expressed concern about an overreliance on China for critical medical supplies, particularly active pharmaceutical ingredients (APIs) used to manufacture drugs. However, there is insufficient data on total API production in the United States and abroad. Official collection of the volume and dollar value of APIs produced per country would be necessary to determine dependence on China with certainty. Find out more HERE
S.2495 - Protecting our Pharmaceutical Supply Chain from China Act of 2021
Latest Senate Bill introduced to reduce our reliance on China for medications
Today, most active pharmaceutical ingredients (APIs) used for drugs in the United States are made in China, including 95% of U.S. imports of ibuprofen, 70% of acetaminophen, and 40-45% of Penicillin. This vulnerable state of affairs is due to the Chinese Communist Party having spent a generation cornering this strategic market. After China covered up the spread of COVID-19 which lead to a global pandemic, a Chinese Communist Party organization asserted that Beijing could “announce strategic control over medical products and ban exports to the United States. Then, the United States will be caught in the ocean of viruses.” China’s duplicity and hostility to the United States has shown that it is past time to move pharmaceutical production out of China.
The Protecting our Pharmaceutical Supply Chain from China Act would:
1. Track Active Pharmaceutical Ingredients: Require the Food and Drug Administration to create a registry of all drugs and corresponding APIs that are produced outside the United States and are determined to be critical to the health and safety of Americans.
2. Prohibit purchases from China: Require that the Department of Health and Human Services, Veterans Affairs, the Department of Defense, and all other federally qualified health facilities purchase pharmaceutical products that have no APIs produced in China. • This requirement will be phased in over two years. The FDA may issue waivers if the APIs are only available in China, however, no waivers may be issued after 2026.
3. Create transparency in the supply chain: Require drug companies to list the APIs and their countries of origin on the labels of imported and domestically produced finished drug products.
4. Provide incentives for manufacturing in the U.S: The legislation will allow immediate expensing for firms that incur costs associated with expanded pharmaceutical or medical device manufacturing within the United States.
Read the Bill and find out more HERE
Congressional Bills to limit Reliance
Background History on Reliance
Featured Item of Interest
Veterans and Opioids
Military making headway on Opioid Epidemic among servicemembers, vets, official say But military retirees who use opioids remain a concern. The majority of long-term opioid patients – 83 percent – are older than 45 years old, most likely to be a retiree or a relative of one and they seek care outside military hospitals and clinics.
Defense Health Agency Director: Progress in Preventing Opioid Abuse, More Needs to Be Done
The Military Health System is making progress in preventing and managing opioid abuse among its beneficiaries, but further actions in education and prevention are needed, the director of the Defense Health Agency said.